For orally inhaled products (OIPs), the AIT provides analysts with data more representative of measured in vivo behaviour, by ensuring that the ISM corresponds with the portion of the aerosol that would likely enter the lungs. With a standardised, highly reproducible, humanlike geometry, the AIT offers robust performance independent of flow rate and is designed to make drug recovery quick and simple.
Idealised geometry represents a range of patient groups
Smooth, uniform internal geometry to allow for coating and to ensure inter-throat uniformity
Quick-release clips make internal coating and drug recovery quick and simple
Chemically compatible with a wide range of drug recovery solvents
Adult and Child (6-14 years) versions available
Regions represented by the AIT
The drug mass sized by the cascade impactor (impactor sized mass) should ideally be representative of the dose that would actually enter the lungs.
The AIT has a four-region resolution:
Knowledge of the portion of the dose captured in the throat is essential to understand the dosage delivery characteristics of a given orally inhaled product (OIP). In many cases, the portion of the dose collected in the throat represents a significant proportion of the delivered dose.
The throat models we offer were developed from extensive research into typical patient populations including information provided by CT and MRI scans, direct observation of living subjects and data in the archival literature. More information and references are available on request.